Seth R. Stevens

Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

Elise A. Olsen, Madeleine Duvic, Arthur E. Frankel et al. · Journal of Clinical Oncology · 2001 · 608 citations

Dysfunctional Blood and Target Tissue CD4+CD25high Regulatory T Cells in Psoriasis: Mechanism Underlying Unrestrained Pathogenic Effector T Cell Proliferation

Hideaki Sugiyama, Rolland Gyulai, Eiko Toichi et al. · The Journal of Immunology · 2005 · 560 citations · Full text

Treg Cell Activity, T-regulatory Cell, Immunology +18

Cost of atopic dermatitis and eczema in the United States

Charles N. Ellis, Lynn A. Drake, Mary M. Prendergast et al. · Journal of the American Academy of Dermatology · 2002 · 213 citations

Allergy, Atopic Dermatitis, Health Economics +4

A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis

Angela Moore, Kenneth B. Gordon, Sewon Kang et al. · Journal of the American Academy of Dermatology · 2006 · 156 citations

Open-label Trial, Continuous Versus, Medicine +9

Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis

James Butler, Sai C. Chan, Seth R. Stevens et al. · Journal of Allergy and Clinical Immunology · 1983 · 145 citations

Inflammation, Asthma, Atopic Dermatitis +7